Date: 2017-10-23
Type of information: Nomination
Compound: vice-president
Company: Adaptimmune (UK)
Therapeutic area: Cancer - Oncology - Autoimmune diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On October 23, 2017, Adaptimmune Therapeutics announced that Sébastien Desprez has joined the Company as vice president of communications and investor relations. Sébastien Desprez was most recently the director of communications at ViiV Healthcare where he developed and implemented the company’s integrated internal and external communications strategy and served as a member of the executive team. Previously, he was the director of communications at GSK, where he headed the communications team supporting the oncology business unit as well as its leadership team. His prior experiences encompass a broad range of senior in-house and agency roles in the pharmaceutical sector, with highlights including work with Roche Global and UK as well as leading accounts for brands such as Tamiflu® and Celebrex®.
Financial terms:
Latest news:
Is general: Yes
